We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Viking Therapeutics stock rose 87% on results for its liver disease drug — and the company has more in store this fall
Business News News
The company’s midstage clinical trial had positive results, and the condition in question affects an estimated 100 million people in the U.S.